Welcome to our dedicated page for Molina Hlthcare SEC filings (Ticker: MOH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to SEC filings for Molina Healthcare, Inc. (NYSE: MOH), a FORTUNE 500 company that provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. These regulatory documents offer detailed insight into how Molina reports its operations, capital structure, and material events.
Among the key filings are Form 8-K current reports, where Molina discloses material developments. Recent 8-Ks describe the private offering of 6.500% Senior Notes due 2031, including interest terms, maturity, ranking, redemption features, and the related indenture. Other 8-Ks outline a new revolving credit facility, amendments to the company’s credit agreement, and a delayed draw term loan used to partially fund a stock repurchase program.
Additional 8-K filings furnish earnings releases for specific quarters, summarizing premium revenue, total revenue, net income, medical care costs, medical care ratios, and segment performance for Medicaid, Medicare, and marketplace operations. These reports also include reconciliations of non-GAAP measures such as adjusted net income, EBITDA, and Adjusted EBITDA, along with explanations of how these metrics are calculated and their limitations.
Investors can also review filings that discuss Medicaid and CHIP contract developments, such as the Notice of Agency Decision indicating an intent to award Molina Healthcare of Florida a Statewide Medicaid Managed Care and Children’s Health Insurance Program contract for the Children’s Medical Services Program. These documents help explain how new or renewed contracts may affect membership and premium revenue.
On Stock Titan, Molina Healthcare’s filings are updated as they are released on EDGAR, and AI-powered summaries highlight the main terms, financial impacts, and segment implications of each document. This allows users to quickly understand complex credit agreements, debt offerings, and earnings disclosures without reading every page of the underlying filing.
The filing shows that Ronna Romney, a director of Molina Healthcare, Inc. (MOH), received an equity grant under the company’s 2025 Equity Incentive Plan on 10/01/2025. The award represents a quarterly portion of the director annual equity retainer of $220,000, with one quarter equal to $55,000. Based on the closing stock price of $192.79 on the grant date, the grant comprised 285 shares.
After the grant, the filing reports 17,416 shares beneficially owned by Ms. Romney, held indirectly through the Ronna Romney Revocable Trust. The Form 4 was signed by a power of attorney on 10/02/2025. The disclosure is a routine director equity compensation report and records the grant price and the indirect ownership vehicle.
T. Rowe Price Associates reported a beneficial ownership stake in Molina Healthcare Inc. totaling 2,207,124 shares, equal to 4.1% of the outstanding common stock. The filing shows the firm has sole voting power over 2,124,376 shares and sole dispositive power over 2,206,422 shares, with no shared voting or dispositive power.
The filing is submitted on Schedule 13G and classifies the filer as an investment adviser. The filer certifies the shares were acquired and are held in the ordinary course of business and states the position was not taken to change or influence control of the issuer, and the filer disclaims beneficial ownership in one section.
Capital Research Global Investors (CRGI) discloses beneficial ownership of 2,166,093 shares of Molina Healthcare common stock, representing 4.0% of 54,200,000 shares believed outstanding. CRGI reports sole voting power over 2,161,524 shares and sole dispositive power over 2,166,093 shares, and identifies itself as an investment adviser organized in Delaware filing under Rule 13d-1(b).
The filing states the position is held in the ordinary course of business and was not acquired to change or influence control of the issuer. Because the stake is under 5%, it is reported on Schedule 13G/A as a passive institutional holding, which signals notable institutional interest without indicating an active control campaign.
Molina Healthcare amended its existing credit facility to add a new Delayed Draw A-2 commitment of $500 million, creating a Term Loan A-2 that matures on August 12, 2027. The new tranche carries an applicable margin of 0.50% for base rate loans and 1.50% for SOFR-based loans and is substantially similar in other terms to the prior credit agreement.
The company states it will use the Term Loan A-2 proceeds to partially fund its previously authorized stock repurchase program as a temporary measure because of the timing of subsidiary dividends to the parent later this year. The amendment and related agreement are included as Exhibit 10.1, with certain schedules omitted from the public filing but available to the SEC upon request. This amendment creates a direct financial obligation under the Amended Credit Agreement.
Ronna Romney, a director of Molina Healthcare (MOH), filed a Form 4 reporting a sale of 700 shares of Molina Healthcare common stock on 08/06/2025 at a volume-weighted average selling price of $153.74 with individual sale prices reported in the range $153.43 to $154.32. The filing shows 17,131 shares are beneficially owned indirectly by the Ronna Romney Revocable Trust. The Form was filed by one reporting person and executed on behalf of Ms. Romney by Jeff D. Barlow under power of attorney on 08/08/2025.
The filing includes an explanatory note that the reported price is the VWAP for sales on the transaction date and offers to provide detailed per-price quantities to Commission staff on request. No derivative transactions are reported and the Form does not state a reason for the sale or explicitly indicate whether the sale was part of a Rule 10b5-1 plan.
Molina Healthcare, Inc. filed a Form 8-K on July 7, 2025 to furnish Item 2.02 information. The company has released a press release (Exhibit 99.1) containing preliminary, unaudited financial results for the second quarter of 2025 and an update to its full-year 2025 adjusted earnings-per-share guidance. No numerical data or qualitative detail is included in the 8-K itself; investors must review the attached press release for specifics. The disclosure is being furnished—not filed—so it is not subject to Section 18 liability or automatically incorporated into other SEC filings. Apart from customary exhibit listings (Exhibit 104 Inline XBRL cover page), the filing reports no other material events, transactions, or changes.
FAQ
What is the current stock price of Molina Hlthcare (MOH)?
What is the market cap of Molina Hlthcare (MOH)?
